These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 8712801)

  • 1. The lupus anticoagulant/antiphospholipid syndrome.
    Shapiro SS
    Annu Rev Med; 1996; 47():533-53. PubMed ID: 8712801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnosis of the antiphospholipid syndrome in anticoagulated patients].
    Mohren M; Daikeler T; Engel A; Guenaydin I; Koetter I
    Z Rheumatol; 2004 Dec; 63(6):490-4. PubMed ID: 15605215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical syndromes associated with lupus anticoagulants.
    Kampe CE
    Semin Thromb Hemost; 1994; 20(1):16-26. PubMed ID: 8059230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of antiphospholipid antibodies].
    Atsumi T; Koike T
    Rinsho Byori; 1998 Apr; 46(4):297-302. PubMed ID: 9594618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical significance and predictive value of laboratory tests in thrombosis associated with antiphospolipid antibodies].
    Barbui T; Finazzi G; Galli M
    Ann Ital Med Int; 1997; 12(2):76-83. PubMed ID: 9333316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Primary antiphospholipid syndrome].
    Popa A; Voinea L; Pop M; Stana D; Dascalu AM; Alexandrescu C; Ciuluvica R
    Oftalmologia; 2008; 52(1):13-7. PubMed ID: 18714484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
    Marai I; Levi Y; Godard G; Shoenfeld Y
    Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome.
    Branch DW; Silver R; Pierangeli S; van Leeuwen I; Harris EN
    Obstet Gynecol; 1997 Apr; 89(4):549-55. PubMed ID: 9083311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiphospholipid sydrome--recurrent thrombosis and foetal loss due to antiphospholipid antibodies].
    Elezović I; Matijević-Aleksić N; Rolović Z
    Srp Arh Celok Lek; 1994; 122(5-6):179-81. PubMed ID: 17977423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
    Musial J; Swadzba J; Motyl A; Iwaniec T
    J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and therapeutic aspects associated to phospholipid binding antibodies (lupus anticoagulant and anticardiolipin antibodies).
    Ordi-Ros J; Pérez-Pemán P; Monasterio J
    Haemostasis; 1994; 24(3):165-74. PubMed ID: 7988946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiphospholipid syndrome: long-time research on pathogenic mechanisms has finally lead to new therapeutic strategies.
    Cervera R; Espinosa G
    Expert Opin Ther Targets; 2010 Dec; 14(12):1279-82. PubMed ID: 21058919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphospholipid and antioangiogenic activity in females with recurrent miscarriage and antiphospholipid syndrome.
    Pelusa HF; Pezzarini E; Basiglio CL; Musuruana J; Bearzotti M; Svetaz MJ; Daniele SM; Bottai H; Arriaga SM
    Ann Clin Biochem; 2017 Sep; 54(5):577-583. PubMed ID: 27638930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent pregnancy loss and antiphospholipid syndrome: an overlooked association.
    Adelowo OO; Adetoro OO
    Afr J Med Med Sci; 2010 Sep; 39(3):227-31. PubMed ID: 21416793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antiphospholipid syndrome].
    Specker C
    Z Rheumatol; 2007 Feb; 66(1):41-50; quiz 51-2. PubMed ID: 17165009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of antiphospholipid antibodies.
    Petri M
    Rheum Dis Clin North Am; 1994 May; 20(2):443-69. PubMed ID: 8016420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiphospholipid syndrome and recurrent miscarriage.
    Rai RS
    J Postgrad Med; 2002; 48(1):3-4. PubMed ID: 12082317
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.